Data from Pivotal Clinical Trials to be Presented in Five Poster Presentations at the 2022 American College of Allergy, Asthma and Immunology Annual Scientific MeetingData Support New Drug Application for neffy®, Currently Under Review with U.S. FDASAN DIEGO – November 10, 2022 - ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) (ARS or...
